» Authors » Geeshath Jayasekera

Geeshath Jayasekera

Explore the profile of Geeshath Jayasekera including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 62
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Craig C, Johnston J, Goodley P, Bishop P, Al-Najjar H, Brown L, et al.
JTO Clin Res Rep . 2024 Aug; 5(8):100694. PMID: 39161961
Introduction: Single-station N2 (ssN2) versus multi-station N2 has been used as a selection criterion for treatment recommendations between surgical versus non-surgical multimodality treatment in stage III-N2 NSCLC. We hypothesized that...
2.
Armato 3rd S, Katz S, Frauenfelder T, Jayasekera G, Catino A, Blyth K, et al.
Lung Cancer . 2024 Jun; 193:107832. PMID: 38875938
Imaging continues to gain a greater role in the assessment and clinical management of patients with mesothelioma. This communication summarizes the oral presentations from the imaging session at the 2023...
3.
Farahmand P, Gyuraszova K, Rooney C, Raffo-Iraolagoitia X, Jayasekera G, Hedley A, et al.
Front Toxicol . 2023 Jul; 5:1200650. PMID: 37441092
Asbestos-driven inflammation contributes to malignant pleural mesothelioma beyond the acquisition of rate-limiting mutations. Genetically modified conditional allelic mice that were previously shown to develop mesothelioma in the absence of exposure...
4.
Murphy G, Jayasekera G, Mullin J, Gallagher L, Welsh D
Pulm Circ . 2022 Sep; 12(3):e12124. PMID: 36092794
Cardiac magnetic resonance (CMR) imaging is used to assess the right ventricle (RV) of pulmonary hypertensive (PH) patients and more recently to track changes in response to therapy. We wished...
5.
Jayasekera G, Wilson K, Buist H, Woodward R, Uckan A, Hughes C, et al.
Pulm Circ . 2020 Feb; 10(1):2045894019897513. PMID: 32095230
Cardiac magnetic resonance-derived ventricular variables are predictive of mortality in pulmonary arterial hypertension. Rodent models which emphasize ventricular function, allowing serial monitoring, are needed to identify pathophysiological features and novel...
6.
Jayasekera G, Johnson M, Hussey K, Church C
SAGE Open Med Case Rep . 2019 May; 7:2050313X19847805. PMID: 31105955
Pulmonary hypertension is a disease process affecting the pulmonary circulation and is defined by an increase in pulmonary artery pressure subsequently causing right ventricular failure. Vascular complications, including arteriovenous fistulae,...
7.
Brash L, Barnes G, Brewis M, Church A, Gibbs S, Howard L, et al.
JACC Basic Transl Sci . 2018 Jun; 3(2):176-186. PMID: 29876530
Apelin agonism causes systemic vasodilatation and increased cardiac contractility in humans, and improves pulmonary arterial hypertension (PAH) in animal models. Here, the authors examined the short-term pulmonary hemodynamic effects of...
8.
Pellino K, Kerridge S, Church C, Peacock A, Crowe T, Jayasekera G, et al.
Eur Respir J . 2018 Feb; 51(2). PMID: 29386345
Several demographic and clinical factors have prognostic significance in idiopathic pulmonary arterial hypertension (IPAH). Studies in China and the USA have suggested an association between low socioeconomic status and reduced...
9.
Crowe T, Jayasekera G, Peacock A
Pulm Circ . 2017 Oct; 8(1):2045893217742000. PMID: 29064323
Pulmonary hypertension (PH) is a progressive illness characterized by elevated pulmonary artery pressure; however, the main cause of mortality in PH patients is right ventricular (RV) failure. Historically, improving the...
10.
Blyth K, Bellofiore A, Jayasekera G, Foster J, Steedman T, Chesler N, et al.
Pulm Circ . 2017 Jun; 7(2):465-475. PMID: 28597775
In pulmonary hypertension (PH), right ventricular (RV) performance determines survival. Pulmonary artery (PA) stiffening is an important biomechanical event in PH and also predicts survival based on the PA relative...